287 related articles for article (PubMed ID: 16249562)
1. Postprandial hyperglycemia is a better predictor of the progression of diabetic retinopathy than HbA1c in Japanese type 2 diabetic patients.
Shiraiwa T; Kaneto H; Miyatsuka T; Kato K; Yamamoto K; Kawashima A; Kanda T; Suzuki M; Imano E; Matsuhisa M; Hori M; Yamasaki Y
Diabetes Care; 2005 Nov; 28(11):2806-7. PubMed ID: 16249562
[No Abstract] [Full Text] [Related]
2. Postprandial hyperglycaemia--its importance and implications.
Lüddeke HJ
Int J Clin Pract Suppl; 1999 Jul; 104():3-7; discussion 18-20. PubMed ID: 12669731
[No Abstract] [Full Text] [Related]
3. The effect of glycaemic control on the quantitative characteristics of retinopathy lesions in patients with type 2 diabetes mellitus: 10-year follow-up study.
Kalesnykiene V; Sorri I; Voutilainen R; Uusitupa M; Niskanen L; Uusitalo H
Graefes Arch Clin Exp Ophthalmol; 2009 Mar; 247(3):335-41. PubMed ID: 19043734
[TBL] [Abstract][Full Text] [Related]
4. Effect of postprandial hyperglycemia at clinic visits on the incidence of retinopathy in patients with type 2 diabetes: An analysis using real-world long-term follow-up data.
Takao T; Takahashi K; Yoshida Y; Kushiyama A; Onishi Y; Tahara T; Shimmei A; Kikuchi T; Suka M; Yanagisawa H; Iwamoto Y; Kasuga M
J Diabetes Investig; 2020 Jul; 11(4):930-937. PubMed ID: 31811705
[TBL] [Abstract][Full Text] [Related]
5. Progression of retinopathy after change of treatment from oral antihyperglycemic agents to insulin in patients with NIDDM.
Henricsson M; Janzon L; Groop L
Diabetes Care; 1995 Dec; 18(12):1571-6. PubMed ID: 8722053
[TBL] [Abstract][Full Text] [Related]
6. Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus.
Esposito K; Giugliano D; Nappo F; Marfella R;
Circulation; 2004 Jul; 110(2):214-9. PubMed ID: 15197140
[TBL] [Abstract][Full Text] [Related]
7. Glycemic variability and diabetes retinopathy: a missing link.
Hsu CR; Chen YT; Sheu WH
J Diabetes Complications; 2015 Mar; 29(2):302-6. PubMed ID: 25534877
[TBL] [Abstract][Full Text] [Related]
8. How often patients on insulin therapy measure postprandial glycemia and modify insulin doses accordingly? From an on-line survey in insulin-treated diabetes patients in Spain.
Lecumberri Pascual E; Tejera Pérez C; Muñoz-Garach A; Javier Ampudia-Blasco F
Diabetes Res Clin Pract; 2019 Aug; 154():43-51. PubMed ID: 31226281
[TBL] [Abstract][Full Text] [Related]
9. Evaluations of retinopathy in the VA Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM). A feasibility study.
Emanuele N; Klein R; Abraira C; Colwell J; Comstock J; Henderson WG; Levin S; Nuttall F; Sawin C; Silbert C; Lee HS; Johnson-Nagel N
Diabetes Care; 1996 Dec; 19(12):1375-81. PubMed ID: 8941467
[TBL] [Abstract][Full Text] [Related]
10. Is fasting glucose variability a risk factor for retinopathy in people with type 2 diabetes?
Zoppini G; Verlato G; Targher G; Casati S; Gusson E; Biasi V; Perrone F; Bonora E; Muggeo M
Nutr Metab Cardiovasc Dis; 2009 Jun; 19(5):334-9. PubMed ID: 18571393
[TBL] [Abstract][Full Text] [Related]
11. [Postprandial glycemia in diabetes patients: assessing this indicator].
Letonturier P
Presse Med; 2006 Dec; 35(12 Pt 1):1855-6. PubMed ID: 17205659
[No Abstract] [Full Text] [Related]
12. Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy.
Klein R; Klein BE; Moss SE; Cruickshanks KJ
Arch Intern Med; 1994 Oct; 154(19):2169-78. PubMed ID: 7944837
[TBL] [Abstract][Full Text] [Related]
13. Rapid preoperative glycemic correction to prevent progression of retinopathy after phacoemulsification in diabetic patients with poor glycemic control.
Suto C; Hori S
J Cataract Refract Surg; 2003 Oct; 29(10):2034-5. PubMed ID: 14604734
[No Abstract] [Full Text] [Related]
14. Defining and characterizing the progression of type 2 diabetes.
Fonseca VA
Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S151-6. PubMed ID: 19875543
[No Abstract] [Full Text] [Related]
15. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.
Abraira C; Colwell JA; Nuttall FQ; Sawin CT; Nagel NJ; Comstock JP; Emanuele NV; Levin SR; Henderson W; Lee HS
Diabetes Care; 1995 Aug; 18(8):1113-23. PubMed ID: 7587846
[TBL] [Abstract][Full Text] [Related]
16. Insulin lispro 25/75 and insulin lispro 50/50 as starter insulin in Japanese patients with type 2 diabetes: subanalysis of the CLASSIFY randomized trial.
Watada H; Imori M; Li P; Iwamoto N
Endocr J; 2017 Jul; 64(7):705-717. PubMed ID: 28539526
[TBL] [Abstract][Full Text] [Related]
17. [Correlation of HBA(1c) and postprandial glycemia during a standard breakfast test in patients with type 2 diabetes mellitus receiving glibenclamide].
Dreval' AV; Cheporeva ON; Red'kin IuA; Misnikova IV
Ter Arkh; 2010; 82(8):41-4. PubMed ID: 20873244
[TBL] [Abstract][Full Text] [Related]
18. Patterns of postprandial hyperglycemia after basal insulin therapy: individual and regional differences.
Shaefer C; Reid T; DiGenio A; Vlajnic A; Zhou R; Ameer B; Riddle M
Diabetes Metab Res Rev; 2015 Mar; 31(3):269-79. PubMed ID: 25255776
[TBL] [Abstract][Full Text] [Related]
19. [A 20-year prospective follow-up study to evaluate the development of retinopathy and nephropathy after the onset of type 1 diabetes mellitus: Contribution of glycemic control and metabolic memory].
Bolotskaya LL; Bessmertnaya EG; Shestakova MV; Shamkhalova MS; Nikankina LV; Ilyin AV; Glek IS; Zolotukhin AV; Dedov II
Ter Arkh; 2017; 89(10):17-21. PubMed ID: 29171465
[TBL] [Abstract][Full Text] [Related]
20. Association between severity of obstructive sleep apnea and glycated hemoglobin level in Japanese individuals with and without diabetes.
Kurosawa H; Saisho Y; Fukunaga K; Haraguchi M; Yamasawa W; Kurihara I; Betsuyaku T; Itoh H
Endocr J; 2018 Jan; 65(1):121-127. PubMed ID: 28931780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
